RETA - Reata Pharmaceuticals Inc
IEX Last Trade
0 0%
Share volume: 0
Last Updated:
Pharmaceutical Preparation Manufacturing :
-2.77%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | |
| Report Date | 2022-05-10 | 2022-08-08 | 2022-11-08 | 2023-02-24 | 2023-05-10 | 2023-08-08 | |
| Total revenue | 914.000 K | 762.000 K | 540.000 K | 0.000 | 195.000 K | 22.746 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 846.000 K | |
| Gross profit | 914.000 K | 762.000 K | 540.000 K | 0.000 | 195.000 K | 21.900 M | |
| -16.63% | -29.13% | -100.00% | inf% | 11,130.77% | |||
| Operating expenses | 64.645 M | 64.474 M | 70.755 M | 79.246 M | 110.362 M | 102.810 M | |
| Selling general and admin | 24.841 M | 25.143 M | 27.270 M | 32.023 M | 54.885 M | 45.690 M | |
| Research and development | 39.804 M | 39.331 M | 43.485 M | 47.223 M | 55.477 M | 57.120 M | |
| Total expenses | 64.953 M | 64.747 M | 71.027 M | 79.523 M | 110.650 M | 103.949 M | |
| -0.32% | 9.70% | 11.96% | 39.14% | -6.06% | |||
| Operating income | -64.039 M | -63.985 M | -70.487 M | -79.523 M | -110.455 M | -81.203 M | |
| Ebit | -64.039 M | -63.985 M | -70.487 M | -79.523 M | -110.455 M | -81.203 M | |
| Pretax income | -73.811 M | -73.556 M | -79.002 M | -85.557 M | -116.117 M | 192.998 M | |
| -0.35% | 7.40% | 8.30% | 35.72% | -266.21% | |||
| Income tax | 31.000 K | -1.000 K | 0.000 | -55.000 K | 0.000 | 0.000 | |
| Net income basic | -73.842 M | -73.555 M | -79.002 M | -85.502 M | -116.117 M | 192.998 M | |
| 0.39% | -7.41% | -8.23% | -35.81% | 266.21% | |||
| Net income | -73.842 M | -73.555 M | -79.002 M | -85.502 M | -116.117 M | 192.998 M | |
| 0.39% | -7.41% | -8.23% | -35.81% | 266.21% |